Fund shareholders of Neurocrine Biosciences Inc
ISIN US64125C1099 · United States · LEI 549300FECER0XBN49756
- Fund shareholders
- 641
- Of which ETFs
- 170 471 other funds
- Value held
- 5.1B $ 1.4B SEK · 12M €
- Share of capital
- 39.5 % of 101.6M shares on Jul 22, 2026
641 funds hold this company: 636 declare it in a regulatory filing, and this table serves those page by page; 5 more are read from the reports their funds publish, and are not in it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund Dodge & Cox Funds | 3,964,000 | 522.2M $ | 0.46 % | 3.90 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Mid-Cap ETF iShares Trust | 3,318,802 | 437.2M $ | 0.41 % | 3.26 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,196,296 | 421.1M $ | 0.02 % | 3.14 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,314,127 | 304.9M $ | 0.19 % | 2.28 % | as of Mar 31, 2026 ↗ |
| JPMorgan Growth Advantage Fund J.P. Morgan Mutual Fund Investment Trust | 1,323,361 | 174.3M $ | 0.86 % | 1.30 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,294,810 | 170.6M $ | 0.44 % | 1.27 % | as of Mar 31, 2026 ↗ |
| JPMorgan Mid Cap Growth Fund JPMorgan Trust II | 1,207,253 | 159M $ | 1.39 % | 1.19 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,120,418 | 147.6M $ | 0.18 % | 1.10 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 727,502 | 95.8M $ | 1.18 % | 0.72 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 654,044 | 86.2M $ | 1.16 % | 0.64 % | as of Mar 31, 2026 ↗ |
| iShares S&P Mid-Cap 400 Growth ETF iShares Trust | 610,411 | 80.4M $ | 0.81 % | 0.60 % | as of Mar 31, 2026 ↗ |
| VictoryShares Free Cash Flow ETF Victory Portfolios II | 607,961 | 80.1M $ | 1.30 % | 0.60 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 593,926 | 78.2M $ | 3.45 % | 0.58 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 556,764 | 73.3M $ | 0.39 % | 0.55 % | as of Mar 31, 2026 ↗ |
| iShares MSCI USA Min Vol Factor ETF iShares Trust | 530,238 | 69.8M $ | 0.31 % | 0.52 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 521,753 | 69M $ | 0.17 % | 0.51 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF SPDR SERIES TRUST | 490,288 | 64.6M $ | 0.41 % | 0.48 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 454,544 | 59.8M $ | 0.27 % | 0.45 % | as of Apr 30, 2026 ↗ |
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 417,300 | 55M $ | 0.22 % | 0.41 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 369,318 | 48.7M $ | 0.10 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 358,706 | 47.2M $ | 0.09 % | 0.35 % | as of Apr 30, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 349,838 | 46.1M $ | 0.57 % | 0.34 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 334,085 | 44M $ | 0.04 % | 0.33 % | as of Mar 31, 2026 ↗ |
| JNL/JPMorgan MidCap Growth Fund JNL Series Trust | 332,025 | 43.7M $ | 1.40 % | 0.33 % | as of Mar 31, 2026 ↗ |
| Dodge & Cox Balanced Fund Dodge & Cox Funds | 304,000 | 40M $ | 0.27 % | 0.30 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 297,785 | 39.4M $ | 0.19 % | 0.29 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 269,663 | 35.7M $ | 0.26 % | 0.27 % | as of Feb 28, 2026 ↗ |
| JPMorgan Active Growth ETF J.P. Morgan Exchange-Traded Fund Trust | 269,225 | 35.5M $ | 0.43 % | 0.26 % | as of Mar 31, 2026 ↗ |
| Carillon Eagle Mid Cap Growth Fund Carillon Series Trust | 242,495 | 31.9M $ | 0.67 % | 0.24 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Aktiefond Pension Swedbank Robur Fonder AB | 241,300 | 302.8M SEK | 0.28 % | 0.24 % | as of Mar 31, 2026 ↗ |
| AB DISCOVERY GROWTH FUND, INC. AB DISCOVERY GROWTH FUND, INC. | 213,095 | 28.1M $ | 1.04 % | 0.21 % | as of Apr 30, 2026 ↗ |
| Carillon Scout Mid Cap Fund Carillon Series Trust | 193,184 | 25.5M $ | 0.68 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap Growth ETF SCHWAB STRATEGIC TRUST | 191,642 | 25.3M $ | 0.05 % | 0.19 % | as of Feb 28, 2026 ↗ |
| First Trust Growth Strength ETF First Trust Exchange-Traded Fund | 186,292 | 24.5M $ | 2.11 % | 0.18 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 186,031 | 24.6M $ | 0.02 % | 0.18 % | as of Feb 28, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 177,263 | 222.5M SEK | 0.02 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Hood River Small-Cap Growth Fund Manager Directed Portfolios | 173,881 | 22.9M $ | 0.44 % | 0.17 % | as of Mar 31, 2026 ↗ |
| JPMorgan Mid Cap Equity Fund JPMorgan Trust I | 167,986 | 22.1M $ | 0.40 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 70 Swedbank Robur Fonder AB | 156,500 | 196.4M SEK | 0.20 % | 0.15 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF SPDR SERIES TRUST | 152,785 | 20.1M $ | 0.81 % | 0.15 % | as of Mar 31, 2026 ↗ |
| VANGUARD S&P MID-CAP 400 INDEX FUND VANGUARD ADMIRAL FUNDS | 151,766 | 20.1M $ | 0.38 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Dodge & Cox Global Stock Fund Dodge & Cox Funds | 151,163 | 19.9M $ | 0.17 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 147,254 | 19.5M $ | 0.02 % | 0.14 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 136,901 | 18M $ | 0.35 % | 0.13 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 135,831 | 18M $ | 0.04 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 135,667 | 17.9M $ | 0.04 % | 0.13 % | as of Apr 30, 2026 ↗ |
| AQR Equity Market Neutral Fund AQR Funds | 135,369 | 17.8M $ | 0.54 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 135,273 | 17.8M $ | 1.72 % | 0.13 % | as of Apr 30, 2026 ↗ |
| Pacer US Large Cap Cash Cows Growth Leaders ETF Pacer Funds Trust | 132,963 | 17.5M $ | 0.81 % | 0.13 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 128,263 | 17M $ | 0.02 % | 0.13 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 127,130 | 16.7M $ | 0.02 % | 0.13 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS | 122,894 | 16.2M $ | 0.16 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 117,823 | 15.5M $ | 0.04 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Columbia Acorn Fund COLUMBIA ACORN TRUST | 116,190 | 15.3M $ | 0.68 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 111,500 | 139.9M SEK | 0.63 % | 0.11 % | as of Mar 31, 2026 ↗ |
| JPMorgan Hedged Equity Fund JPMorgan Trust I | 110,027 | 14.5M $ | 0.07 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 103,691 | 13.7M $ | 0.02 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Mid Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 101,844 | 13.4M $ | 1.40 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Nuveen Quant Mid Cap Growth Fund TIAA-CREF Funds | 101,830 | 13.4M $ | 1.96 % | 0.10 % | as of Apr 30, 2026 ↗ |
| JNL Mid Cap Index Fund JNL Series Trust | 101,269 | 13.3M $ | 0.41 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 101,202 | 13.3M $ | 0.39 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Allspring Diversified Capital Builder Fund ALLSPRING FUNDS TRUST | 100,000 | 13.2M $ | 0.68 % | 0.10 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 95,188 | 12.5M $ | 0.01 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental U.S. Small Company ETF SCHWAB STRATEGIC TRUST | 91,230 | 12.1M $ | 0.12 % | 0.09 % | as of Feb 28, 2026 ↗ |
| VANGUARD S&P MID-CAP 400 GROWTH INDEX FUND VANGUARD ADMIRAL FUNDS | 90,951 | 12M $ | 0.73 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Distillate U.S. Fundamental Stability & Value ETF ETF Series Solutions | 88,671 | 11.7M $ | 0.65 % | 0.09 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P U.S. Growth ETF iShares Trust | 85,490 | 11.3M $ | 0.04 % | 0.08 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 84,489 | 11.1M $ | 0.01 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 82,521 | 10.9M $ | 0.02 % | 0.08 % | as of Apr 30, 2026 ↗ |
| EQ/Mid Cap Index Portfolio EQ Advisors Trust | 82,266 | 10.8M $ | 0.41 % | 0.08 % | as of Mar 31, 2026 ↗ |
| HARTFORD CAPITAL APPRECIATION HLS FUND HARTFORD SERIES FUND INC | 80,396 | 10.6M $ | 0.31 % | 0.08 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 79,833 | 10.5M $ | 0.03 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Franklin U.S. Mid Cap Multifactor Index ETF Franklin Templeton ETF Trust | 79,648 | 10.5M $ | 0.63 % | 0.08 % | as of Mar 31, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 79,256 | 10.4M $ | 0.55 % | 0.08 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 78,721 | 10.4M $ | 0.16 % | 0.08 % | as of Feb 27, 2026 ↗ |
| AMG GW&K Small/Mid Cap Core Fund AMG Funds | 78,459 | 10.3M $ | 1.44 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Healthcare Swedbank Robur Fonder AB | 77,300 | 97M SEK | 0.68 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Mid Cap Index Fund VALIC Co I | 76,144 | 10.1M $ | 0.38 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Impax Small Cap Fund IMPAX FUNDS SERIES TRUST I | 75,000 | 9.9M $ | 1.33 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Columbia Mid Cap Index Fund COLUMBIA FUNDS SERIES TRUST | 73,522 | 9.7M $ | 0.38 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Franklin Global Allocation Fund Franklin Fund Allocator Series | 71,834 | 9.5M $ | 0.34 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 80 Swedbank Robur Fonder AB | 71,500 | 89.7M SEK | 0.09 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Marketwide Value ETF Dimensional ETF Trust | 70,547 | 9.3M $ | 0.06 % | 0.07 % | as of Apr 30, 2026 ↗ |
| John Hancock Multifactor Mid Cap ETF John Hancock Exchange-Traded Fund Trust | 70,038 | 9.2M $ | 0.19 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 70,000 | 9.2M $ | 1.39 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Mercer US Small/Mid Cap Equity Fund Mercer Funds | 68,898 | 9.1M $ | 0.53 % | 0.07 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 68,750 | 9.1M $ | 0.02 % | 0.07 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 68,514 | 9.1M $ | 0.43 % | 0.07 % | as of Feb 28, 2026 ↗ |
| AQR Large Cap Defensive Style Fund AQR Funds | 67,068 | 8.8M $ | 0.65 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Nuveen Quant Small/Mid Cap Equity Fund TIAA-CREF Funds | 66,484 | 8.8M $ | 0.34 % | 0.07 % | as of Apr 30, 2026 ↗ |
| SA JPMorgan Mid-Cap Growth Portfolio SUNAMERICA SERIES TRUST | 65,575 | 8.6M $ | 1.30 % | 0.06 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 63,518 | 8.4M $ | 0.02 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Allspring SMID Cap Growth Fund ALLSPRING FUNDS TRUST | 63,334 | 8.3M $ | 1.03 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Mid Cap Index Fund Northern Funds | 63,096 | 8.3M $ | 0.41 % | 0.06 % | as of Mar 31, 2026 ↗ |
| AQR Style Premia Alternative Fund AQR Funds | 60,807 | 8M $ | 0.35 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 59,693 | 7.9M $ | 0.02 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 59,024 | 7.8M $ | 0.02 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 58,463 | 7.7M $ | 0.02 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 58,204 | 7.7M $ | 0.03 % | 0.06 % | as of Feb 28, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 57,454 | 7.6M $ | 0.87 % | 0.06 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 4.66 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 3.68 % | as of Apr 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.45 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 3.22 % | as of Mar 31, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 3.16 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.15 % | as of Sep 30, 2025 ↗ |
| Baird Small/Mid Cap Growth Fund Baird Funds Inc | 2.94 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 2.86 % | as of Apr 30, 2026 ↗ |
| MUTUAFONDO SALUD, FI MUTUACTIVOS, S.A., S.G.I.I.C. | 2.59 % | as of Dec 31, 2025 ↗ |
| Thompson MidCap Fund Thompson IM Funds, Inc. | 2.21 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 600 | -3 | 39,005,444 | -0.7 % |
| 2026Q1 | 603 | -9 | 39,263,230 | -4.2 % |
| 2025Q4 | 612 | +11 | 40,996,168 | -4.4 % |
| 2025Q3 | 601 | -6 | 42,897,103 | +2.8 % |
| 2025Q2 | 607 | -27 | 41,721,880 | +7.3 % |
| 2025Q1 | 634 | -24 | 38,886,077 | +4.9 % |
| 2024Q4 | 658 | -8 | 37,086,789 | -2.5 % |
| 2024Q3 | 666 | +50 | 38,056,358 | +5.0 % |
| 2024Q2 | 616 | +15 | 36,239,577 | +1.1 % |
| 2024Q1 | 601 | +31 | 35,855,892 | +2.7 % |
| 2023Q4 | 570 | 34,930,179 |
Institutional managers
682 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 13,385,607 | 1.8B $ | as of Mar 31, 2026 |
| Dodge & Cox | 5,461,037 | 719.4M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 5,442,067 | 700.5M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 4,938,967 | 650.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,354,526 | 573.7M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,060,570 | 403.2M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,418,897 | 318.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,136,672 | 280.8M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,493,813 | 196.8M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,389,539 | 183.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,250,000 | 164.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,247,447 | 164.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,242,830 | 163.7M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,221,036 | 160.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,219,196 | 160.6M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 1,062,072 | 139.9M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 959,217 | 126.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 902,788 | 118.9M $ | as of Mar 31, 2026 |
| IEQ CAPITAL, LLC | 765,982 | 100.9M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 731,609 | 96.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 724,000 | 95.4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 711,762 | 93.8M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 702,492 | 92.5M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 652,121 | 85.9M $ | as of Mar 31, 2026 |
| Fiera Capital Corp | 651,255 | 85.8M $ | as of Mar 31, 2026 |
Declared shareholders of Neurocrine Biosciences Inc
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 5.23 % | 5,257,941 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Neurocrine Biosciences Inc". https://titelia.com/en/stocks/neurocrine-biosciences-inc-US64125C1099